glp-1 clinical studies Timeline of discovery and development. (a) Key events in List of Clinical Trials Evaluating

v2.2.2 Logged out hard work gone I loved this app overall but it recently logged me out and I cant get it to recover my account

& Lachin, J

Bibcode:1996PhRvL..77...99L

Click [...] To view or add a comment, sign in $NVO has started a Phase 1 trial for its new obesity drug candidate LX9851, developed with Lexicon Pharmaceuticals The drug is oral and works differently from current GLP-1 treatments, targeting fat metabolism and satiety signals The study will assess safety in overweight and obese patients, with results expected in Q1 2027 Lexicon receives a $10M milestone payment and could earn up to $1B plus royalties if successful #stocks #Investing To view or add a comment, sign in 16,813 followers